Last updated: July 17, 2026

Application No. 17/258,112

COMPOSITION CONTAINING A 7BETA-HYDROXYCHOLESTEROL AND A LIPID VEHICLE, AND ITS USE IN THE TREATMENT OF NEOPLASTIC PATHOLOGIES

Non-Final OA

Filed

Jan 05, 2021

Priority

Jul 11, 2018 — EU 18305933.6 +1 more

Examiner

KUCHARCZK, JED A

Art Unit

1623

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

BETA INNOV

OA Round

5 (Non-Final)

Interview Optional

— +16.9% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 80% grant rate with +16.9% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.

Based on 93 resolved cases, 2023–2026

Examiner Intelligence

KUCHARCZK, JED A View full profile →

Grants 80% — above average

Career Allowance Rate

74 granted / 93 resolved

+19.6% vs TC avg

Strong +17% interview lift

Without

With

+16.9%

Interview Lift

resolved cases with interview

Typical timeline

2y 9m

Avg Prosecution

36 currently pending

Career history

126

Total Applications

across all art units

Statute-Specific Performance

§101

0.8%

-39.2% vs TC avg

§103

44.1%

+4.1% vs TC avg

§102

19.4%

-20.6% vs TC avg

§112

9.5%

-30.5% vs TC avg

Black line = Tech Center average estimate • Based on career data from 93 resolved cases

Prosecution Timeline

Show 6 earlier events

Jul 11, 2024

Response after Non-Final Action

Dec 12, 2024

Non-Final Rejection mailed

Jun 12, 2025

Response Filed

Oct 01, 2025

Final Rejection mailed

Feb 02, 2026

Response after Non-Final Action

Feb 27, 2026

Request for Continued Examination

Mar 09, 2026

Response after Non-Final Action

Apr 15, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/802,307

Patent 12679827

PYRIMIDINE COMPOUNDS AND THEIR PHARMACEUTICAL USES

3y 10m to grant Granted Jul 14, 2026

18/852,508

Patent 12661344

SAFE AND STABLE NIMODIPINE FORMULATION FOR INJECTION AND METHOD FOR PREPARING SAME

1y 8m to grant Granted Jun 23, 2026

18/317,990

Patent 12642789

CARBOXAMIDE DERIVATIVES

3y 0m to grant Granted Jun 02, 2026

16/965,252

Patent 12629349

Recognition ability improving agent

5y 9m to grant Granted May 19, 2026

17/796,449

Patent 12630529

GCN2 MODULATOR COMPOUNDS

3y 9m to grant Granted May 19, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6

Expected OA Rounds

80%

Grant Probability

96%

With Interview (+16.9%)

2y 9m (~0m remaining)

Median Time to Grant

High

PTA Risk

Based on 93 resolved cases by this examiner. Grant probability derived from career allowance rate.

COMPOSITION CONTAINING A 7BETA-HYDROXYCHOLESTEROL AND A LIPID VEHICLE, AND ITS USE IN THE TREATMENT OF NEOPLASTIC PATHOLOGIES

Interview Optional

Examiner Intelligence

Statute-Specific Performance

Prosecution Timeline

Precedent Cases

Applications granted by this same examiner with similar technology

Strategy Recommendation AI-generated — please review before filing

Prosecution Projections

Ready to respond to this office action?

Sign in with your work email